Tag: Akebia

FDA, Regulations

FDA approves Akebia anemia pill, two years after rejection

March 28, 2024

Via: Biopharma Dive

Drug developers have studied pills like Jesduvroq and Vafseo as alternatives to injectable biologic drugs like Amgen’s Epogen in the hopes they would be safer and more convenient. Rather than mimicking a natural blood-boosting protein called erythropoietin as the biologics […]


Akebia reveals sweeping layoffs and vadadustat partial clinical hold after FDA snub

April 7, 2022

Via: FiercePharma

After safety concerns derailed an approval of Akebia Therapeutics’ blockbuster hopeful vadadustat late last month, the company warned that a restructuring was in the cards. This week, Akebia telegraphed job cuts for nearly half of its workforce and revealed deeper […]